Home › Castration-Resistant Prostatic Cancer › Florida
Castration-Resistant Prostatic Cancer clinical trials in Florida
4 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Florida.
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Bay Pines VA Healthcare System, Bay Pines
- Florida Cancer Specialists & Research Institute, Fort Myers
- Moffitt Cancer Center, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07164443A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- AdventHealth Orlando, Orlando
- Memorial Cancer Institute, Pembroke Pines
- Florida Cancer Specialists, Sarasota
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07225946Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Jacksonville
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Oct 29, 2026 · NCT05519449A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Florida Cancer Specialists Sarasota Drug Development Unit, Sarasota
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT06067841From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.